BUDEALFA
BudesonideBUDEALFA (Budesonide) is a second-generation synthetic glucocorticoid, effective in treating patients with IgAN at high risk of progression in terms of reducing proteinuria, hematuria and preserving renal function. It is a gastro-resistant, pH-modified formulation with a maximum release of active compound in the distal ileum and proximal colon. Additionally, it has an extensive first-pass metabolism…
Know More


